Roadmap for ending TB in China by 2035: The challenges and strategies-Reference-Cited by-同舟云学术

Roadmap for ending TB in China by 2035: The challenges and strategies

Published:2024-02-29 Issue:1 Volume:18 Page:11-20
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Feng Qishun¹,Zhang Guoliang¹,Chen Liang²,Wu Huizhong³,Yang Yingzhou⁴,Gao Qian¹⁵,Asakawa Tetsuya¹,Zhao Yanlin⁶,Lu Shuihua¹,Zhou Lin¹⁷,Lu Hongzhou¹

Affiliation:

1. National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.

2. Guangdong Provincial Research Center for Public Health, Guangdong Provincial Center for Diseases Control and Prevention, Guangzhou, Guangdong, China.

3. Guangdong Provincial Center for Tuberculosis Control, Guangzhou, Guangdong, China.

4. Shenzhen Center for Chronic Disease Control, Shenzhen, Guangdong, China.

5. School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai, China.

6. National Tuberculosis Reference Laboratory, Chinese Center for Disease Control and Prevention, Beijing, China.

7. Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Link

https://www.jstage.jst.go.jp/article/bst/18/1/18_2023.01325/_pdf

Reference43 articles.

1. 1. Floyd K, Glaziou P, Zumla A, Raviglione M. The global tuberculosis epidemic and progress in care, prevention, and research: An overview in year 3 of the End TB era. Lancet Respir Med. 2018; 6:299-314.

2. 2. Falzon D, den Boon S, Kanchar A, Zignol M, Migliori GB, Kasaeva T. Global reporting on tuberculosis preventive treatment among contacts. Eur Respir J. 2022; 59.

3. 3. World Health Organization. Global Tuberculosis Report. 2023. https://www.who.int/publications/i/item/9789240083851 (accessed December 27, 2023).

4. 4. Hoagland DT, Liu J, Lee RB, Lee RE. New agents for the treatment of drug-resistant Mycobacterium tuberculosis. Adv Drug Deliv Rev. 2016; 102:55-72.

5. 5. Carter DJ, Glaziou P, Lonnroth K, Siroka A, Floyd K, Weil D, Raviglione M, Houben R, Boccia D. The impact of social protection and poverty elimination on global tuberculosis incidence: A statistical modelling analysis of Sustainable Development Goal 1. Lancet Glob Health. 2018; 6:e514-e522.